Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?

IHE delivered stronger 5-year returns, but VHT's 0.09% expense ratio and 411 holdings offer broader diversification at lower cost.

Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?

Published July 22, 2026 · Category: Finance

Overview

Vanguard Health Care ETF (NYSEMKT:VHT) provides broad-based sector coverage with a significantly lower expense ratio, while iShares U.S. Pharmaceuticals ETF (NYSEMKT:IHE) offers concentrated access to domestic drug companies.

Both ETFs provide targeted healthcare exposure, but they differ significantly in scope and cost. While one drills down into the specific mechanics of drug development and distribution, the other casts a wider net across the entire medical ecosystem to capture providers, services, and equipment.

Details

Beta measures price volatility relative to the S&P 500; beta is calculated from monthly returns over the available fund history (up to five years). The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield as of the close of trading on July 20.

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.